Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP684083.RARsG-5wUbzbYjA-Cx0WBpiKHi9ch4WhnL-FhzQuMkdjM130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684083.RARsG-5wUbzbYjA-Cx0WBpiKHi9ch4WhnL-FhzQuMkdjM130_provenance.
• NP691659.RA60FKS93wkecCXiFvOg9gxy4VSuQi1uSF1YWUJeACqDs130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691659.RA60FKS93wkecCXiFvOg9gxy4VSuQi1uSF1YWUJeACqDs130_provenance.
• NP575495.RAsg5bHZf6w_5AANMezRvWb34K0yf7HNR13iVFAkc07XI130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575495.RAsg5bHZf6w_5AANMezRvWb34K0yf7HNR13iVFAkc07XI130_provenance.
• NP770206.RAW_yHt7UhEuyGD_3-M165fabHWNkIV6u1iu8T8znGwFQ130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770206.RAW_yHt7UhEuyGD_3-M165fabHWNkIV6u1iu8T8znGwFQ130_provenance.
• NP772042.RAeVIPxQGvtKZ_a-qoivshlJe3k6xtM5NbybldZKPEGpk130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772042.RAeVIPxQGvtKZ_a-qoivshlJe3k6xtM5NbybldZKPEGpk130_provenance.
• NP820265.RAwRmrsmNnb09nlUxotYZYWMV2aBIr1ZkgGjnVXjm1sJo130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820265.RAwRmrsmNnb09nlUxotYZYWMV2aBIr1ZkgGjnVXjm1sJo130_provenance.
• NP820262.RAfTVwVL3N2G5f0HMz5jNhubASzS0ibRxuDn-QIhgmjl4130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820262.RAfTVwVL3N2G5f0HMz5jNhubASzS0ibRxuDn-QIhgmjl4130_provenance.
• NP820266.RATRq4-tMcMJqCIqw3dQExFT7vfctziLjJQ2gNaZtyT-M130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820266.RATRq4-tMcMJqCIqw3dQExFT7vfctziLjJQ2gNaZtyT-M130_provenance.
• assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP820264.RAPVyrJdzf_jMoYP4KrhLiaclScbZSejJZGFbC5OKWr-U130_assertion description "[In diabetes, over-production of NO might play a role in the development of diabetic nephropathy, while reduced NO production may be related to the development of diabetic retinopathy and neuropathy, where VEGF (vascular endothelial growth factor) levels are increased in a counter regulatory manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820264.RAPVyrJdzf_jMoYP4KrhLiaclScbZSejJZGFbC5OKWr-U130_provenance.